Treatment of cervical osteochondrosis and gonarthrosis with Fizomed paraffin-containing applications.
Abstract submitted for the IX Russian National “Man and Human Health” Congress,
22-26 November, St. Petersburg
Head of the Chair of Traumatology and Orthopedics of the Russian Peoples Friendship University, Doctor of Medical Sciences, Prof. N. V. Zagorodniy,
Candidate of Medical Sciences, neurologist I. L. Zagorodnyaya, MD,
Highest Category Physician I. D. Vlasova, MD
Polyclinic № 173, Moscow City Clinical Hospital № 31, Moscow
Application of paraffin in the treatment of diseases of the musculoskeletal apparatus has long been known. The domestic company Fizomed has developed a method to treat osteochondrosis and arthrosis deformans that involves the use of paraffin applicators treated beforehand with electromagnetic field. Paraffin is shaped into inserts and placed into cotton knee-pieces flanking the knee-cap.
For the treatment of osteochondrosis, there is a backpack-like device in which the paraffin inserts are laid so that they flank the spinous processes of the vertebrae. Paraffin exerts its therapeutic activity at human body temperature and does not need to be warmed to 50-60 °С in advance. Applicators should be worn, when possible, continuously for a period of at least three months.
In the process of treatment, three consecutive stages are observed in the clinical picture: elimination of pain syndrome, condition stabilization, and regression of the pathological process.
For our study of paraffin-containing applicators, we selected 27 patients with cervical osteochondrosis and 26 individuals with gonarthrosis.
The mean duration of disease was 7 ± 0.5 years, there were 4 male patients and 39 females, the mean age of subjects was calculated to be 58 ± 1.2 years.
In the clinical picture, we paid attention to changes in pain syndrome, edema of articular soft tissues (swelling), severity of synovitis, skin temperature over the joint, range of motion, and strength of the upper extremities.
In the process of treatment with paraffin-containing applicators, patients used no nonsteroidal anti-inflammatory drugs, analgesics or glucocorticosteroids, which might affect clinical manifestations of their disease.
After the end of treatment, we observed the highest efficacy for the paraffin-containing applicators in patients with gonarthrosis stages 1 and 2 and a low efficacy in patients with stage 3 of disease.
In cervical osteochondrosis, effect was observed in patients with short duration of disease.
To make the obtained treatment results in patients with gonarthrosis objective, we performed rheovasography of the lower extremities in 17 subjects. Assessed parameters included rheowave amplitude, rheowave period, systolic wave length, the rheographic index, an elasticity measure, and the asymmetry value.
In 23 patients with cervical osteochondrosis, rheovasography of the upper extremities and rheoencephalography of the principal neck vessels were carried out.
All studies were performed before treatment and at 3 months after the start of it.
Our investigations have demonstrated that the use of paraffin-containing applicators stabilizes and increases the amplitude of sphygmic blood flow in the cerebral vessels, as well as in the blood vessels of the upper and lower extremities; recovers vascular tone; diminishes significantly (and eliminates completely in a number of cases) the sphygmic blood flow asymmetry in the cerebral vessels and vessels of the upper and lower extremities. At the same time, venous outflow and elasticity of the vascular wall in the blood vessels of the neck and the extremities remain unaltered. No negative changes in the course of disease were observed in this study.
The obtained results validate the subjective data implying positive effects of the Fizomed paraffin-containing applicators used as a part of complex treatment in diseases of the musculoskeletal apparatus.